Skip to content

Clinical study of time-restricted diet in the treatment of thyroid-related ophthalmopathy

Clinical study of time-restricted diet in the treatment of thyroid-related ophthalmopathy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059096
Enrollment
Unknown
Registered
2022-04-24
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid eye disease

Interventions

Sponsors

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University,
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age 18-75 years old; Suffering from thyroid-related eye disease (TAO); TAO grade <= grade III; Can persist in observation for more than 2 months; Be able to understand the purpose of the trial, volunteer to participate in the researcher of this subject, and sign the informed consent form

Exclusion criteria

Exclusion criteria: History of other diseases other than hyperthyroidism, metabolic dysfunction, abnormal physical examination, or suspicious diseases or conditions found in clinical laboratory tests that may have contraindications to drug use or affect test results or make subjects prone to treatment complications, such as severe liver disease Impaired renal function and/or serious systemic diseases (such as cardiovascular system, respiratory system, digestive system, nervous system, endocrine system, genitourinary system diseases, etc.); Systemic infection under treatment; Liver and kidney dysfunction; History of drug abuse or alcoholism; Received drug clinical trials within 1 month (excluding vitamins and minerals); Any situation that the research doctor believes that the patient's condition will hinder the clinical trial (such as the patient is prone to mental stress, uncontrollable emotions, depression, etc.); Poor patient compliance, unable to complete the trial process as required.

Design outcomes

Primary

MeasureTime frame
proptosis;

Countries

China

Contacts

Public ContactRong Lu
tosying@gmail.com18826428044

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026